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TECHNICAL REPORT
DIFFERENTIATION OF Candida dubliniensis FROM Candida albicans WITH THE USE 
OF KILLER TOXINS
Liliane A. SCHEID(1), Débora A. Nunes MARIO(1), Elizabeth Maria HEINS-VACCARI(2), Janio Morais SANTURIO(3) & Sydney Hartz ALVES (1,3)
SUMMARY
The aim of this study was to report the ability of killer toxins, previously used as biotyping techniques, as a new tool to differentiate 
C. albicans from C. dubliniensis. The susceptibility of C. albicans and C. dubliniensis to killer toxins ranged from 33.9 to 93.3% and 
from 6.67 to 93.3%, respectively.
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Killer toxins are glucoprotein compounds secreted by Hansenula and 
Picchia strains, which may cause pores in the cytoplasmatic membrane 
of the Candida albicans, inhibiting its growth. Because the susceptibility 
of C. albicans to killer toxins is variable, the phenomenon was employed 
as a method to biotype different C. albicans strains2,3,6. In recent years, 
biotyping techniques have been advantageously substituted by molecular 
methods.
Since 1995 when C. dubliniensis was proposed as a new species 
of Candida genera, many techniques have been studied in order to 
phenotypically differentiate this species from C. albicans because both 
species are germ tube positive and form chlamydospores in corn meal 
agar14. 
Nowadays, the definitive identification of C. dubliniensis requires 
molecular methods and thus old phenotypic tests have been re-evaluated, 
as well as new tests having been proposed for phenotypic identification. 
Among them, we can emphasize: niger seed agar13, sunflower agar7, 
sesame seed agar9 based on chlamydoconidia production, and colonial 
morphology. Other tests include absence of opacity on Tween 80 agar4, 
coaggregation of C. dubliniensis with Fusobacterium nucletaum5, 
inability of C. dubliniensis to grow in hypertonic broth (NaCl 6.5%)1, 
and to grow at temperatures of 42 °C or 45 °C10. Among commercially 
disposable methods, the CHROMagar Candida8 and Bichro-Dublin 
Fumouze®12 are worthy of mention. 
The aim of this study was to investigate the ability to differentiate C. 
albicans from C. dubliniensis based on susceptibilities to killer toxins 
as proposed by POLONELLI et al. (1983). The yeasts employed for 
the assays were: Hansenula sp Stumm 1034 (K1), Pichia sp Stumm 
1035 (K2), Hansenula anomala UM (K3), Hansenula anomala CBS 
5759 (K4), Hansenula anomala Ahearn UN 866 (K5), Hansenula 
californica Ahearn WC 40 (K6), Hansenula canadensis Ahearn WC 41 
(K7), Hansenula dimmenae Ahearn WC 44 (K8), and Hansenula mrakit 
Ahearn W1C51 (K9)
The susceptibility of C. albicans and C. dubliniensis to killer toxins 
ranged from 33.3% to 93.3% and from 6.67% to 93.3%, respectively. 
Twenty-one biotypes were registered and the code numbers 111, 611, 
and 211 were the most frequently observed in both species. No biotypes 
occurred as a particular characteristic of C. dubliniensis and thus the killer 
toxins were unable to differentiate C. albicans from C. dubliniensis. As 
far as we know, this technique had not been explored until now. 
RESUMO
Avaliação das toxinas killer na diferenciação entre Candida 
albicans e Candida dubliniensis
Avaliou-se a capacidade das toxinas killer, previamente utilizadas na 
biotipagem de C. albicans, como método para diferenciar C. albicans 
de C. dubliniensis. A susceptibilidade de C. albicans e C. dubliniensis 
às toxinas killer variou de 33,9% a 93,3% para C. albicans e de 6,67% 
a 93,3% para C. dubliniensis. 
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